Vote of confidence
22.07.2015 - June Raine has been confirmed as Chair of the European Pharmacovigilance Risk Assessment Committee (PRAC). At its July 2015 meeting, the committee of the European Medicines Agency voted to prolong the mandate of Raine by another three years.
Raine’s colleague Álmath Spooner was also confirmed as co-chair. Raine holds a PhD and undertook postgraduate research leading to an MSc in pharmacology. Today, she is Director of Vigilance and Risk Management of Medicines at the Medicines and Healthcare products Regulatory Agency (MHRA) of the UK. She has served as chair of the PRAC since September 2012.
Her key priorities for the future of the PRAC are: to evaluate the outcome of its pharmacovigilance activities and decisions in terms of measurable public health benefit; to ensure pharmacovigilance and risk management systems are key enablers of earlier access for patients to innovative medicines; and to continue to progress the way in which the PRAC engages with healthcare professionals, patients and the public to deliver regulatory decisions.http://www.european-biotechnology-news.com/people/bio-people/2015/june-raine.html